The opportunity: Why brands are launching testing products
The at-home diagnostics market has exploded. Consumers now expect their trusted wellness brands — not just doctors — to offer testing. Supplement companies want to prove product efficacy with biomarker data. Sports nutrition brands want to guide athletes by measuring recovery and metabolic status. Telehealth platforms need testing to enable remote diagnosis and monitoring.
For your brand, white-label testing is a new revenue stream, a competitive moat, and a way to own customer health data that feeds product recommendations and loyalty. The barrier to entry is lower than ever when you partner with an accredited laboratory.
What white-label testing actually means
White-label means the lab does the science — method development, validation, accreditation, sample analysis, and compliance — while your brand owns the customer experience. Your name appears on the report. You set the price. You control the narrative around the test and the results.
The lab becomes your invisible partner: they validate biomarkers, achieve regulatory certification, build the logistics chain, and guarantee turnaround time and accuracy. You focus on marketing, customer acquisition, and product positioning. It's a partnership model that lets you move fast without building a 50-person laboratory operation.
The roadmap: Six critical steps from concept to launch
Step 1: Define your biomarker panel. What story do you want to tell your customer? If you sell performance supplements, you might test protein metabolism (amino acids, creatinine, urea). If you're in women's health, hormone panels (estradiol, progesterone, FSH) make sense. Work with your lab partner to identify 6-15 biomarkers that align with your product and customer needs.
Step 2: Validate the method. Your lab partner will confirm that the chosen biomarkers can be measured accurately from a dried blood spot using their established analytical methods — typically LC-MS/MS, GC-FID, or HPLC. This phase usually takes 4-8 weeks and ensures reproducibility and reliability.
Step 3: Design the collection kit. Partner with a collection device manufacturer to design your branded finger-prick kit. The kit includes lancet, collection card, packaging, and return envelope. Sample stability at room temperature during postal transit is critical for dried blood spot testing.
Step 4: Navigate regulatory requirements. This varies by market. In the US, you need a CLIA-certified laboratory. In the EU, CE marking of the collection device may be required. In Australia and the UK, accreditation standards apply. Start early: regulatory consultation should happen in month one, not month eight.
Step 5: Build the logistics chain. How do customers order? How do they receive and return the collection kit? How are samples tracked, accessioned, and analyzed? Your lab partner should operate sample logistics, but you need to integrate it with your e-commerce platform and customer communication.
Step 6: Launch and iterate. Start with a soft launch to a subset of customers to catch operational issues before scaling. Use early feedback to refine the biomarker panel, adjust pricing, and improve the customer journey. Most brands continue to add biomarkers or new test variants in the 12 months after launch.
Why an accredited lab partner is non-negotiable
Accreditation means the lab has been independently audited and certified to meet international quality standards — CLIA in the US, ISO 15189 in Europe, NATA in Australia. This protects your brand from regulatory risk, patient lawsuits, and reputational damage if results are wrong.
An accredited partner also brings method breadth: they've already validated 30+ biomarkers using LC-MS/MS, so your new test doesn't start from zero. They have cold-chain logistics, quality control systems, and personnel trained in diagnostic compliance. You're buying decades of accumulated infrastructure.
Timeline, cost, and competitive advantage
Expect 6-12 months from concept to commercial launch. Simpler panels using established methods take 4-6 months. Novel biomarkers or regulatory complexity can extend to 12-18 months. Your lab partner's method portfolio and geographic accreditation (US, UK, EU, Australia) dramatically accelerates this timeline.
The competitive advantage is speed to market. Brands that launch a testing product in 8 months capture customers before competitors even start planning. That early adopter premium — higher margins, stronger brand loyalty, first-party data — compounds over years.
Frequently asked questions
What is the typical timeline for launching a white-label blood test kit?
From initial biomarker selection to commercial launch typically takes 6-12 months, depending on regulatory complexity and method validation status. Simpler tests using established methods at accredited labs may launch in 4-6 months, while novel biomarker panels or new geographic markets can take 12-18 months due to regulatory requirements and method optimization.
Can I launch a white-label test kit without developing my own laboratory?
Yes. A contract laboratory partner handles all method development, validation, accreditation, and sample analysis. Your brand owns customer relationships and commercial strategy while the lab manages the science and compliance. This approach is faster to market, lower capital cost, and reduces regulatory risk compared to building in-house laboratory capacity.
What regulatory approval do I need for a direct-to-consumer blood test kit?
Regulatory requirements vary by market. In the US, CLIA certification of the laboratory is essential. In the EU, CE marking may apply to the collection device. In Australia and the UK, national accreditation standards apply. Your lab partner should guide compliance strategy, but you should involve regulatory consultants early to avoid costly delays at launch.
Partner with Masdiag
We support supplement brands, sports nutrition companies, telehealth platforms, and health tech startups with white-label diagnostic testing. Our accreditation in US, EU, UK, and Australia accelerates your launch.
Get in Touch →